Health Care & Life Sciences » Biotechnology | Human Stem Cells Institute PJS

Human Stem Cells Institute PJS

Human Stem Cells Institute PJS
Stock Exchange Moscow Exchange
EPS
RUB0.46
Market Cap
RUB1.09 B
Shares Outstanding
-
Public Float
-

Profile

Address
18/1, Olimpiyskiy Avenue
Moscow MC 129110
Russian Federation
Employees -
Website http://www.hsci.ru
Updated 07/08/2019
Human Stem Cells Institute OJSC engages in the discovery, research, development, and marketing of proprietary products and services in the field of regenerative medicine, medical genetics, bio-insurance, gene therapy, and biopharmaceutics. Its research and development involves gemacell and cryocell; service for personal regeneration of bone and of gum; nucleostim; preventive treatment program for primary immunodeficiency diseases; human artificial chromosome; development of drugs using histone proteins; and development of drugs using a novel technology employing polysialic acid. The company was founded by Isaev Alexandrovich Artur on November 3, 2003 and is headquartered in Moscow, Russia.

Financials

View All
Created with Highcharts 5.0.14Human Stem Cells Institute PJSNet Income. Fiscal year is January-December. All values RUB Thousands.14 72214 72213 19313 19351 53751 537111 309111 309102 601102 60134 20834 208201320142015201620172018025k50k75k100k125k
Created with Highcharts 5.0.14Human Stem Cells Institute PJSSales/Revenue. Fiscal year is January-December. All values RUB Thousands.419 770419 770359 371359 371310 821310 821390 356390 356494 441494 441644 688644 6882013201420152016201720180200k400k600k800k

Alexander Viktorovich Prikhodko
Chairman & Deputy General Director
Artur Alexandrovich Isaev
General Director & Director